IPO - Caring Brands, Inc.

Form Type: S-1

Filing Date: 2025-03-20

Corporate Action: Ipo

Type: New

Accession Number: 000149315225011039

Filing Summary: Caring Brands, Inc. has filed a Registration Statement under the Securities Act of 1933 for an initial public offering (IPO) of up to 750,000 shares of common stock at an anticipated price of $4.00 per share, signaling the company's intent to go public. The offering will include a resale prospectus for an additional 6,220,000 shares. The shares are aimed for listing on the NASDAQ Capital Markets under the symbol 'CABR'. The company is classified as an emerging growth company and intends to comply with reduced public company reporting requirements. The registration document outlines the different forms of prospectuses contained within for both the IPO and potential resale, highlighting specific sections that differ between the two. The company reports that it aims to relaunch Photocil, a treatment for vitiligo and psoriasis, in the U.S. market after previously being removed due to poor sales. It discusses significant market potential for phototherapy in India and globally, citing expected growth in the psoriasis treatment market, while also detailing its ownership of proprietary technology and pending licensing agreements in various countries. However, it also warns that demand and market penetration depend on external factors such as competition, regulatory conditions, and the establishment of a dedicated sales team. The filing stresses that investments are speculative and involve risks, a caution reiterated throughout the prospectus.

Document Link: View Document

Form Type: DRS/A

Filing Date: 2025-02-11

Corporate Action: Ipo

Type: New

Accession Number: 000149315225005964

Filing Summary: Caring Brands, Inc. is filing to register for an initial public offering (IPO) of up to 1,000,000 shares of common stock at an anticipated price of $4.00 per share. The firm commitment offering will be underwritten and is contingent upon NASDAQ listing approval under the symbol 'CABR'. This registration statement also includes a resale prospectus for 6,220,000 shares of common stock from selling shareholders, which consist of shares issued via private placements and shares held by the parent company, Safety Shot, Inc. Previously, the company encountered challenges marketing its product Photocil in the U.S. after a brief launch period, and it aims to relaunch this product in 2025. The company is classified as an emerging growth company and a smaller reporting company, allowing them to apply reduced public company reporting requirements. The offering will not proceed if the common stock is not approved for NASDAQ listing.

Document Link: View Document

Form Type: DRS/A

Filing Date: 2025-01-17

Corporate Action: Ipo

Type: New

Accession Number: 000149315225002843

Filing Summary: Caring Brands, Inc. intends to conduct an initial public offering (IPO) of up to 1,000,000 shares of its common stock, priced at approximately $4.00 per share, to be listed on NASDAQ under the symbol 'CABR'. The registration statement is being filed confidentially, with a structure allowing for alternate prospectuses for resale by stockholders totaling up to 6,220,000 shares. The registration involves the distribution of shares from Safety Shot, Inc. to its stockholders. This announcement outlines that no public market exists for the company's shares at this time, and the offering's completion is contingent on regulatory approval for listing. The prospectus includes details about the company's emerging growth company status and the implications of this designation, including a reduced reporting burden. It also highlights that investment in these securities carries risks, and that prior projections about sales and financial performance are contingent upon various factors, including market demand and regulatory hurdles.

Document Link: View Document

Form Type: DRS/A

Filing Date: 2024-12-20

Corporate Action: Ipo

Type: New

Accession Number: 000149315224051003

Filing Summary: Caring Brands, Inc. filed a confidential draft registration statement for its initial public offering (IPO) on December 20, 2024. The company plans to issue up to 1,000,000 shares of common stock at an anticipated IPO price of $4.00 per share, targeting a total raise of $4,000,000. The company also registered an additional 6,220,000 shares for resale by selling shareholders, including 2,110,000 private shares issued through private placements, 2,110,000 shares from warrant exercises, and 2,000,000 distributed shares from its parent company, Safety Shot, Inc. The IPO and resale prospects are fundamentally similar, with variations in layout and sections to reflect their specific uses. The registration highlights Caring Brands' classification as a smaller reporting and emerging growth company under the JOBS Act, which permits reduced disclosure requirements. The offering is contingent on NASDAQ listing approval, under symbol 'CABR'. The company’s wellness products include patented treatments for skin conditions like vitiligo and psoriasis and hair regrowth products that have undergone clinical trials. The document outlines anticipated use of proceeds, underwriter fees, and the speculative nature of the investment. The prospectus emphasizes risks and forward-looking statements surrounding market entry and product efficacy.

Document Link: View Document

Form Type: DRS

Filing Date: 2024-10-18

Corporate Action: Ipo

Type: New

Accession Number: 000149315224041631

Filing Summary: Caring Brands, Inc. filed a confidential draft registration statement for an initial public offering (IPO) with the SEC on October 18, 2024. The company plans to offer up to 1,000,000 shares of its common stock at an anticipated initial offering price of $4.00 per share. This is part of a firm commitment offering and includes a resale of an additional 6,220,000 shares owned by selling stockholders. The filing also notes the company's strategy to seek a listing on NASDAQ and outlines significant financial projections, such as anticipated gross proceeds of $4,000,000 from the IPO. It emphasizes the company's emerging growth status under the JOBS Act, indicating it may opt for reduced public reporting obligations. Additionally, the document highlights recent developments, including prior private placements and collaborations that align with the company's goal to expand its product portfolio in the health and wellness markets, such as dermatological products and at-home diagnostic devices.

Document Link: View Document